Artboard 11

New method for treating benign pleural effusions used for the first time worldwide at MedUni Vienna/University Hospital Vienna

In a world first, a novel diaphragmatic valve was used to treat benign pleural effusions in two patients at the Department of Thoracic Surgery at MedUni Vienna and University Hospital Vienna. This represents an important step forward in the treatment of this common and debilitating condition, which can improve patients' quality of life with just a single procedure.

Benign pleural effusions often occur as a result of heart, kidney or liver disease and lead to shortness of breath. Until now, patients have had to undergo regular punctures to remove fluid from the pleural space – the space between the lungs and the chest wall. This often requires external drainage or the lungs to be fully expanded in order to achieve adhesion of the two pleural layers and thus prevent further fluid accumulation.

The new, minimally invasive implantable valve now offers a much gentler and, above all, permanent alternative: it allows excess fluid to drain through the diaphragm into the abdominal cavity, where it is absorbed by the body itself. This eliminates the need for repeated punctures and external drainage.

Improving quality of life with a single procedure

With this procedure, we have a way of relieving patients of shortness of breath, the main symptom of pleural effusions, with a single procedure," explains Clemens Aigner, Head of the Department of Thoracic Surgery at MedUni Vienna and University Hospital Vienna. ‘This innovative method represents a new treatment principle in which the effusion is drained from the pleura into the abdominal cavity via a valve mechanism.’

The two patients treated at University Hospital Vienna to date no longer require punctures and report a significantly improved quality of life. The next step is to scientifically investigate the application of the procedure in a prospective study.

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.